Influence of Eggs on Cognitive Performance
NCT06465888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2025-09-29
Summary
This clinical trial aims to evaluate the nutrients in eggs in healthy adult's cognitive performance. The main questions it aims to answer are:
* How do the nutrients in eggs impact visual cognitive performance (VCP) in generally healthy older individuals?
* Will omega-3 fatty acids in eggs improve VCP in generally healthy older individuals?
Participants will be randomly placed in one of five dietary treatment groups, including four egg whites, two whole regular eggs, two whole omega-3 fortified eggs, four egg yolks, and a no-egg control. Blood will be drawn at baseline. During the first two weeks, participants will eat assigned eggs, consume their usual diet other than the eggs, and keep five food logs. Cognitive performance testing will start on day 15 and be measured over a 10-day period using the Neurotracker (NT) 3-D program. Data on ancillary factors influencing outcomes will be collected, and food will be logged on each NT training day. Blood will be drawn at the end of the study and compared with baseline levels.
Conditions
- Cognitive Function
Interventions
- OTHER
-
egg whites
Participants will eat four egg whites daily for the 4-week study
- OTHER
-
whole eggs
Participants will eat two eggs daily for the 4-week study
- OTHER
-
Omega-3 eggs
Participants will eat two Christopher Farms omega-3 fortified eggs daily for the 4-week study.
- OTHER
-
egg yolk
Participants will eat four egg yolks daily for the 4-week study
Sponsors & Collaborators
-
Egg Nutrition Center
collaborator OTHER - lead OTHER
Principal Investigators
-
Steven E. Riechman, PhD · Texas A&M University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 50 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-22
- Primary Completion
- 2020-03-19
- Completion
- 2020-03-19
Countries
- United States
Study Locations
More Related Trials
-
Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels
NCT03781557 ·Status: UNKNOWN ·Phase: PHASE4
-
Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease
NCT01058941 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
High Dose Omega 3 in People at Risk for Dementia
NCT03926351 ·Status: UNKNOWN ·Phase: PHASE2
-
Omega-3 Fatty Acids and Subconcussive Head Impacts
NCT06736925 ·Status: RECRUITING ·Phase: NA
-
Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
NCT00480207 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
n-3 PUFA for Vascular Cognitive Aging
NCT01953705 ·Status: UNKNOWN ·Phase: PHASE2
-
The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild Dementia
NCT04972643 ·Status: COMPLETED ·Phase: NA
-
The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players
NCT03582267 ·Status: COMPLETED ·Phase: NA
-
Polyunsaturated Fatty Acids (PUFA) Status and Cognitive Function in Healthy Young Adults
NCT01075958 ·Status: COMPLETED
-
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
NCT01746303 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases
NCT03072823 ·Status: COMPLETED ·Phase: NA
-
A Study of Omega-3 as a Treatment for Major Depression
NCT00238758 ·Status: UNKNOWN ·Phase: PHASE2
-
Open-Label Study of Omega 3 Oil Supplementation for Aging-Related Cognitive Decline
NCT04484454 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Unsaturated Fatty Acid Improves Cognitive Function in Patients With Depression
NCT04803071 ·Status: UNKNOWN ·Phase: NA
-
Synergistic Activity of Human Milk Nutrients and Infant Cognition
NCT03838536 ·Status: RECRUITING ·Phase: NA
-
The Combination Effect of Citicoline and Omega-3
NCT03444662 ·Status: COMPLETED ·Phase: NA
-
Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention
NCT01780974 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Infant Egg Consumption on Child Health and Cognition Development
NCT04345185 ·Status: COMPLETED
-
Fish Oil (Omega 3), Immune Function, and Mood
NCT00385723 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omega-3 Phospholipids on Perceptual-cognitive Training
NCT01856829 ·Status: COMPLETED ·Phase: NA
-
N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical Subtypes
NCT03871088 ·Status: COMPLETED ·Phase: NA
-
Improvement of Fish Oil in Obesity With Mild Cognitive Impairment
NCT06992726 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Omega 3 Fatty Acid Trial
NCT00586222 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia
NCT06933095 ·Status: RECRUITING ·Phase: NA
-
Omega-3 Fatty Acids for Treating Adults With Major Depression
NCT00517036 ·Status: COMPLETED ·Phase: PHASE3